A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila

Nature Genetics
A KazantsevLeslie Michels Thompson

Abstract

Huntington disease is caused by the expansion of a polyglutamine repeat in the Huntingtin protein (Htt) that leads to degeneration of neurons in the central nervous system and the appearance of visible aggregates within neurons. We have developed and tested suppressor polypeptides that bind mutant Htt and interfere with the process of aggregation in cell culture. In a Drosophila model, the most potent suppressor inhibits both adult lethality and photoreceptor neuron degeneration. The appearance of aggregates in photoreceptor neurons correlates strongly with the occurrence of pathology, and expression of suppressor polypeptides delays and limits the appearance of aggregates and protects photoreceptor neurons. These results suggest that targeting the protein interactions leading to aggregate formation may be beneficial for the design and development of therapeutic agents for Huntington disease.

References

Nov 5, 1992·Nature·D B NikolovS K Burley
Dec 1, 1989·Developmental Biology·R L Cagan, D F Ready
Oct 22, 1982·Science·G M Rubin, A C Spradling
Feb 1, 1995·Seminars in Cell Biology·J F Gusella, M E MacDonald
Jan 1, 1993·Cold Spring Harbor Symposia on Quantitative Biology·R Lande, F W Stahl
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·M F PerutzJ T Finch
Nov 6, 1998·Brain Pathology·G P BatesS W Davies
Dec 16, 1998·The Journal of Cell Biology·M K PerezR N Pittman
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·E ScherzingerE E Wanker
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·A KazantsevD Housman
Mar 10, 2000·Science·P Kazemi-Esfarjani, S Benzer
Apr 1, 2000·Journal of Neuropathology and Experimental Neurology·E M SigurdssonB Frangione
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·J S SteffanL M Thompson
Jun 9, 2000·Annual Review of Neuroscience·H Y Zoghbi, H T Orr
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·P J MuchowskiF U Hartl
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·J CarmichaelD C Rubinsztein
Aug 25, 2000·Human Molecular Genetics·A McCampbellK H Fischbeck
Oct 19, 2000·Neuroscience·D P McGowanR G Snell

❮ Previous
Next ❯

Citations

Mar 11, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Motomasa TanakaNobuyuki Nukina
Jul 3, 2009·Molecules and Cells·Seongman Kang, Sunghoi Hong
Aug 10, 2002·Current Neurology and Neuroscience Reports·Russell L Margolis
Aug 14, 2003·Current Neurology and Neuroscience Reports·Leslie Michels Thompson, J Lawrence Marsh
Oct 3, 2003·Biochemical and Biophysical Research Communications·Hetal Parekh-Olmedo, Eric B Kmiec
Mar 17, 2004·Current Opinion in Pharmacology·Marta M Lipinski, Junying Yuan
May 14, 2003·Progress in Retinal and Eye Research·Teresa Borrás
Apr 4, 2003·The International Journal of Biochemistry & Cell Biology·Geoffrey M Goellner, Martin Rechsteiner
Sep 27, 2002·Current Opinion in Pharmacology·Sanjay Tickoo, Steven Russell
May 2, 2008·Chemical Reviews·Andras Bauer, Brent Stockwell
May 16, 2006·Nature Chemical Biology·David W ColbyK Dane Wittrup
Apr 22, 2004·Nature Reviews. Neuroscience·M Flint Beal, Robert J Ferrante
Apr 24, 2007·Nature Structural & Molecular Biology·Pingwei LiPamela J Bjorkman
Jan 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·H Akiko PopielTatsushi Toda
Aug 20, 2003·Human Molecular Genetics·J Lawrence MarshLeslie M Thompson
Sep 25, 2003·Human Molecular Genetics·Andrej Michalik, Christine Van Broeckhoven
Aug 23, 2008·Human Molecular Genetics·Bruno MugatFlorence Maschat
Jan 12, 2007·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Ray TruantAnjee Burtnik
Jun 8, 2006·Annual Review of Genomics and Human Genetics·Trudy F C Mackay, Robert R H Anholt
Sep 24, 2011·Advances in Pharmacological Sciences·Varsha ShuklaHarish C Pant
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Tzu-Kang Sang, George R Jackson
Feb 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Nikolaos Giagtzoglou, Hugo J Bellen
Jan 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christopher A RossMario Amzel
Dec 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Peter W FaberAnne C Hart
Feb 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Wyan-Ching Mimi LeeJ Troy Littleton
May 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Barbara L ApostolLeslie Michels Thompson
Aug 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·William J WolfgangAnne Messer
Jan 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqian ZhangAleksey G Kazantsev
Feb 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·S IuchiH Green
Sep 28, 2006·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Ray TruantRandy Singh Atwal
Jul 3, 2003·Médecine sciences : M/S·Jean-Charles Liévens, Serge Birman
Jul 14, 2009·Neurobiology of Disease·Mei LiMarc I Diamond
Jan 24, 2007·Progress in Neurobiology·Ray TruantAnjee Burtnik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.